Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Market Cap	32.80M
Revenue (ttm)	34.95M
Net Income (ttm)	-40.10M
Shares Out	84.96M
EPS (ttm)	-0.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,812
Average Volume	77,655
Open	38.90
Previous Close	39.20
Day's Range	38.20 - 39.70
52-Week Range	26.60 - 47.50
Beta	1.08
RSI	49.32
Earnings Date	May 29, 2025

About TLV:TKUN

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd was incorporated in 2023 and is based in Nof HaGalil, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2023
• Employees: 19
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TKUN

Financial Performance

In 2024, TLV:TKUN's revenue was 34.95 million, a decrease of -20.97% compared to the previous year's 44.23 million. Losses were -40.10 million, -54.88% less than in 2023.